Building a biofoundry
Synthetic Biology · 17.02.2021 · 6 (1)
DOI: 10.1093/synbio/ysaa026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Synthetic Biology, online erschienen am 16.12.2020. Verfasst von Maciej B Holowko und 4 weiteren Autor:innen. Beteiligte Einrichtung: CSIRO Synthetic Biology Future Science Platform, CSIRO Land and Water, Brisbane, QLD 4102, Australia. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council.
Abstract (Originalsprache)
A biofoundry provides automation and analytics infrastructure to support the engineering of biological systems. It allows scientists to perform synthetic biology and aligned experimentation on a high-throughput scale, massively increasing the solution space that can be examined for any given problem or question. However, establishing a biofoundry is a challenging undertaking, with numerous technical and operational considerations that must be addressed. Using collated learnings, here we outline several considerations that should be addressed prior to and during establishment. These include drivers for establishment, institutional models, funding and revenue models, personnel, hardware and software, data management, interoperability, client engagement and biosecurity issues. The high cost of establishment and operation means that developing a long-term business model for biofoundry sustainability in the context of funding frameworks, actual and potential client base, and costing structure is critical. Moreover, since biofoundries are leading a conceptual shift in experimental design for bioengineering, sustained outreach and engagement with the research community are needed to grow the client base. Recognition of the significant, long-term financial investment required and an understanding of the complexities of operationalization is critical for a sustainable biofoundry venture. To ensure state-of-the-art technology is integrated into planning, extensive engagement with existing facilities and community groups, such as the Global Biofoundries Alliance, is recommended.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CSIRO Synthetic Biology Future Science Platform, CSIRO Land and Water, Brisbane, QLD 4102, Australia.
- School for the Future of Innovation in Society and School of Biological & Health Systems Engineering, Arizona State University, Tempe, AZ 85287, USA.
- Law Futures Centre, Griffith Law School, Griffith University, Nathan, QLD 4111, Australia.
- ARC Centre of Excellence in Synthetic Biology, Queensland University of Technology, Brisbane, QLD 4001, Australia.
ORCID-Profile: Maciej B Holowko, Claudia E Vickers
Förderung
- European Research Council
Zitieren
APA
Holowko, M. B., Frow, E. K., Reid, J. C., Rourke, M., & Vickers, C. E. (2021). Building a biofoundry. Synthetic Biology, 6(1). https://doi.org/10.1093/synbio/ysaa026
Vancouver
Holowko MB, Frow EK, Reid JC, Rourke M, Vickers CE. Building a biofoundry. Synthetic Biology. 2021;6(1). doi:10.1093/synbio/ysaa026
BibTeX
@article{Holowko2021,
author = {Holowko, Maciej B and Frow, Emma K and Reid, Janet C and Rourke, Michelle and Vickers, Claudia E},
title = {Building a biofoundry},
journal = {Synthetic Biology},
year = {2021},
volume = {6},
number = {1},
doi = {10.1093/synbio/ysaa026}
}
EUVIMED